Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06436300 · ClinicalTrials.gov registry record · NA

Colorectal Cancer Screening in Alaska Native Men

A NA study, sponsored by Washington State University.

Completed
Registry status
NA
Development phase
998
Enrollment target

NCT06436300 is a NA study that has completed, run by Washington State University. The registered enrollment target is 998 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06436300, a NA study, has completed, sponsored by Washington State University.

COMPLETED
Registry status
NA
Development phase
998 participants
Enrollment target

Study Summary

Alaska Native men have the highest rates of colorectal cancer incidence and mortality in the US. Screening can prevent disease and improve survival. A previous study tested text messages to increase colorectal cancer screening in Alaska Native patients of the Southcentral Foundation healthcare system in Anchorage, Alaska. The intervention improved screening by 50% in women, but it had no effect in men. The current study aimed to culturally tailor the intervention for Alaska Native Men, and to test it with a randomized controlled trial among patients at the Southcentral Foundation.

Interventions

  • BEHAVIORAL Motivational text messaging

Trial Details

FieldValue
Enrollment Target 998 participants
Start Date 2023-08-01
Est. Completion 2024-01-31
Phase NA

Sponsor

Washington State University

64 total trials

What the Registry Record Tells You About NCT06436300

The ClinicalTrials.gov registry entry for NCT06436300 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 998 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Motivational text messaging is the first listed.

NCT06436300 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06436300 about?

NCT06436300 is a clinical study titled "Colorectal Cancer Screening in Alaska Native Men". Alaska Native men have the highest rates of colorectal cancer incidence and mortality in the US. Screening can prevent disease and improve survival. A previous study tested text messages to increase colorectal cancer screening in Alaska Native patients of the Southcentral Foundation healthcare syste...

What is the current status of trial NCT06436300?

This trial is currently completed. It is a NA study. The enrollment target is 998 participants. The study started on 2023-08-01. Estimated completion is 2024-01-31.

What interventions are being tested in trial NCT06436300?

The interventions under investigation include: Motivational text messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT06436300?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.